Kyle J. Tynan

Kyle J. Tynan

Auto-generated profile, based on publicly available information

Kyle J. Tynan

National Institute of Standards and Technology (NIST) Gaithersburg Maryland USA

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2026 in Biochimie
Verified
Journal Article
Closed access
KTKyle J. Tynan
Kyle J. Tynan
MLMark S. Lowenthal
Mark S. Lowenthal
KSKarndeep Singh
Karndeep Singh
TMTrina Mouchahoir
Trina Mouchahoir
DHDaniel Hunter
Daniel Hunter
KPKaren W. Phinney
Karen W. Phinney

20 March 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
KTKyle J. Tynan
Kyle J. Tynan
TMTrina Mouchahoir
Trina Mouchahoir
MLMark S. Lowenthal
Mark S. Lowenthal
KPKaren W. Phinney
Karen W. Phinney
DsRNA is a highly immunogenic byproduct formed during IVT of mRNA that results in unwanted immunostimulatory responses and reduces vaccine efficacy. Multiple different versions of dsRNA impurities are believed to exist (loopback dsRNA, sense-antisense dsRNA, and short abortive primers). Current industry methods for testing dsRNA content suffer from long processing times, low repeatability, and are unable to differentiate between types of dsRNA impurities. Detecting dsRNA with a typical bioseparation is challenging, as dsRNA impurities and mRNA co-elute. In this paper, we develop a size-exclusion chromatography method for rapidly detecting and separating dsRNA impurities from the target mRNA product. This brings analysis time down from 24 h to 20 min. Using SEC, dsRNA impurities can be completely resolved from the mRNA.

17 June 2026 in Biomedical Chromatography
Verified
Journal Article
Closed access
KTKyle J. Tynan
Kyle J. Tynan
TMTrina Mouchahoir
Trina Mouchahoir
MLMark S. Lowenthal
Mark S. Lowenthal
KPKaren W. Phinney
Karen W. Phinney